FAS and lung cancer: Activated efficient T lymphocytes were cleared by the Fas/FasL-mediated apoptosis pathway (71), and the expression level of the Fas (CD95) antigen on peripheral blood T cells of patients with lung malignant tumors was significantly higher than that of healthy individuals (72).